This broad and high-level report examines the emerging epigenetics market. This world market includes important biomedical product areas that will have a powerful impact on healthcare delivery and personalized medicine. This business report analyzes key market segments such life science research tools, diagnostics and therapeutics.
Many people already know about DNA, genes and the human genome. The DNA code defines the structure of who we are, our potential health and our characteristics that we pass on to our children. Epigenetics refers to the second code of life and links environmental impacts to a person' s health. Epigenetic mechanisms signal how and when genes are activated or silenced.
This research study discusses the market for life science tools and technologies that support epigenetics R&D. The report discusses important technologies, equipment and consumables including microarray, next-generation sequencing, PCR and other platforms. Topics such as microRNA and human stem cells are lightly covered.
The report covers subjects including important epigenetic factors including DNA methylation, histone modifications and others. The study discusses epigenetic biomarkers, commercial diagnostics and therapeutics that will foster personalized medicine. The study highlights new epigenetic diagnostics. This research examines the current epigenetic therapeutics on the market and drugs in the clinical pipeline. The report highlights major government grant initiatives such as the NIH' s ‘Roadmap Epigenomics Program' initiatives, the EU' s ‘Epigenetic Network of Excellence' and others.
This study discusses important epigenetics topics and provides the reader with key findings. The data estimates that the worldwide epigenetics market value will reach multi-billions of dollars in 2010, with a strong double-digit growth rate. This report reviews the activities of 35 companies. The study uses 39 figures and tables to illustrate the findings. This study includes many valuable tables that help the reader scan the details of major trends, market segmentation, forecast, M&As, partnerships, grant funding, patents and so on.
This must-have report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.
Analysts at Takeda Pacific developed this report. The company provides business consulting that focuses on facilitating business development and market research projects. The business projects may involve European, Japanese and North American Life Science companies. Since it' s founding in late 1992, TP has reviewed or analyzed thousands of life Science and technology firms for its clients.
Since 1992, Takeda Pacific has produced numerous industry reports about emerging pharma, biotech, medical devices and technology companies and markets. Takeda Pacific also offers follow-up consulting or custom research consulting to assist in your business development or benchmarking, market assessment projects.
Browse more Gene Therapeutics & RNAi Market Research Reports